Bictegravir Receives Expanded Indication by FDA to Treat HIV

Patients with HIV who have suppressed viral loads and pre-existing resistance will be able to use bictegravir with this FDA approval.

Related Keywords

United States , American , Jared Baeten , Paule Sax , Harvard Medical School , Division Of Infectious Diseases , Clinical Development , Gilead Sciences , Olivier Le Moal , Clinical Director , Infectious Diseases , Vice President , American Journal ,